Straub, Rainer H <br/><br/>
Anti-interleukin-6 receptor antibody therapy favors adrenal androgen secretion in patients with rheumatoid arthritis: a randomized, double-blind, placebo-controlled study.  [electronic resource] 

 -  Arthritis and rheumatism  Jun 2006 
 - 1778-85 p.  digital 
<br/><br/> Publication Type: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0004-3591 
<br/><br/><label>Standard No.: </label>10.1002/art.21826  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>17-alpha-Hydroxyprogesterone--blood<br/>Adrenal Glands--metabolism<br/>Adrenocorticotropic Hormone--blood<br/>Adult<br/>Aged<br/>Androgens--metabolism<br/>Androstenedione--blood<br/>Antibodies, Monoclonal--therapeutic use<br/>Arthritis, Rheumatoid--therapy<br/>Dehydroepiandrosterone--blood<br/>Dehydroepiandrosterone Sulfate--blood<br/>Double-Blind Method<br/>Estradiol--blood<br/>Estrone--blood<br/>Female<br/>Humans<br/>Hydrocortisone--blood<br/>Male<br/>Middle Aged<br/>Prednisolone--therapeutic use<br/>Receptors, Interleukin-6--immunology